News | Ultrasound Imaging
October 2, 2018 — GE Healthcare announced an equity investment in SonoSim, which specializes in ultrasound education and ...
October 02, 2018
Videos | Womens Cardiovascular Health
Cindy Grines, M.D., chair and professor, department of cardiology, Zucker School of Medicine, Hostra/Northwell, spoke on ...
October 01, 2018
Ashish Pershad, M.D., medical director, structural heart program, Banner University Medical Heart Institute, Phoenix ...
October 01, 2018Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News | Stents Drug Eluting
October 1, 2018 — Recent results from the BIONYX randomized clinical study showed the novel, thin-strutted, polymer ...
October 01, 2018
Technology | Stents Drug Eluting
Boston Scientific announced that the U.S. Food and Drug Administration (FDA) has approved its Premarket Approval (PMA) application to market the Eluvia Drug-Eluting Vascular Stent System, specifically developed for the treatment of peripheral artery disease (PAD). The Eluvia stent utilizes a drug-polymer combination to offer sustained release of the drug paclitaxel for a one-year timeframe, designed to prevent tissue regrowth that might otherwise block the stented artery.
October 01, 2018
Feature | Dave Fornell, Editor
October 1, 2018 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...
October 01, 2018Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News | Stents Bioresorbable
New results from the RENASCENT studies presented at the Transcatheter Cardiovascular Therapeutics (TCT) conference showed Amaranth Medical’s Magnitude sirolimus-eluting bioresorbable scaffold (BRS) continued to perform well clinically at nine months.
October 01, 2018
Videos | Hemodynamic Support Devices
Nevin Kapur, M.D., FAHA, FACC, FSCAI, executive director, Cardiovascular Center for Research and Innovation, Tufts ...
October 01, 2018
News | Heart Failure
Heart failure patients who received the Carillon Mitral Contour System in the REDUCE FMR clinical trial showed a statistically significant reduction in regurgitant volume at one year compared to the control cohort receiving guideline-directed medical therapy. Results of the REDUCE FMR trial were presented at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego.
September 28, 2018Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News | Ultrasound Imaging
Clarius Mobile Health is introducing the Clarius Cart at the American College of Emergency Physicians (ACEP) 2018 Scientific Assembly, Oct. 1-4 in San Diego. The Clarius Cart is an ultrasound accessory to complement the company’s lineup of wireless ultrasound scanners for use in more traditional settings. It is a mobile cart with a lockable cabinet to hold scanners, a working space for procedures, and a charging dock for scanner batteries and smart devices. It is designed for hospital and clinical environments to give clinicians the flexibility of personal ultrasound with the utility of traditional cart-based systems, without any cables.
September 28, 2018
News | Heart Valve Technology
September 28, 2018 — At one year following transcatheter aortic valve replacement (TAVR), implantation with the Portico ...
September 28, 2018
News | Artificial Intelligence
September 28, 2018 — Artificial intelligence (AI) driven by machine learning (ML) algorithms is a branch in the field of ...
September 28, 2018Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News | Heart Valve Technology
The first randomized study to compare general versus local anesthesia during transcatheter aortic valve replacement (TAVR) in patients with intermediate to high surgical risk found local anesthesia to be both safe and effective. In addition, the study found that a current generation balloon-expandable valve had similar outcomes to a current generation self-expanding one.
September 28, 2018
Videos | Hemostasis Management
Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at ...
September 27, 2018
Technology | Stents
September 27, 2018 — Biotronik recently announced U.S. Food and Drug Administration (FDA) approval of the PK Papyrus ...
September 27, 2018© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now